Sign in
4

Changes in Ownership

Apnimed, Inc. Filed Acc 0001193125-26-330505

Options or other derivatives

  • Chief Executive Officer acquired 1,478,238 shares (grant or award)
  • Chief Executive Officer returned 1,369,322 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lind Kevin Robert Chief Executive Officer 2026-08-03 Returned to the company · Stock Option (Right to Buy) −74,128 0 D: show line 1 in the form
Lind Kevin Robert Chief Executive Officer 2026-08-03 Grant or award · Stock Option (Right to Buy) +74,128 74,128 D: show line 2 in the form
Lind Kevin Robert Chief Executive Officer 2026-08-03 Returned to the company · Stock Option (Right to Buy) −1,186,278 0 D: show line 3 in the form
Lind Kevin Robert Chief Executive Officer 2026-08-03 Grant or award · Stock Option (Right to Buy) +1,186,278 1,186,278 D: show line 4 in the form
Lind Kevin Robert Chief Executive Officer 2026-07-30 Grant or award · Stock Option (Right to Buy) +108,916 108,916 D: show line 5 in the form
Lind Kevin Robert Chief Executive Officer 2026-08-03 Returned to the company · Stock Option (Right to Buy) −108,916 0 D: show line 6 in the form
Lind Kevin Robert Chief Executive Officer 2026-08-03 Grant or award · Stock Option (Right to Buy) +108,916 108,916 D: show line 7 in the form
Loading xslF345X06/ownership.xml…